A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics.

Thanaporn Wattanakul Palang Chotsiri Ivan Scandale Richard M Hoglund Joel Tarning

Published in: Expert review of clinical pharmacology (2022)

activity data to clinically expected drug exposures, and could therefore be a useful compliment to other methods in order to prioritize repurposed drugs for evaluation in prospective randomized controlled clinical trials.

Keyphrases